The global demand for Drug-eluting Balloon Catheters Market is presumed to reach the market size of nearly USD 1218.74 MN by 2028 from USD 629.4 MN in 2021 with a CAGR of 9.9% under the study period 2022 - 2028.
Drug-eluting Balloon Catheters (DEBCs) are medical devices used to treat narrowed or blocked blood vessels in the body. DEBCs are inserted into the blood vessel using a catheter, a thin tube guided through the vessel using x-ray imaging. Once the catheter is properly positioned, the balloon is expanded, which causes the medication to be released. DEBCs are typically used to treat peripheral artery disease (PAD), which occurs when the blood vessels in the legs become narrowed or blocked.
Market Dynamics
The market's growth is expected to be driven by the growing number of patients suffering from peripheral and cardiovascular diseases. The market is expected to expand as there is an increasing preference for minimally invasive procedures and advancements in technology for drug-coated balloon catheters. Moreover, the market share has been significantly impacted by the increase in the elderly population. The ageing population is more prone to peripheral artery disease, driving demand for DEBCs as a treatment option. Furthermore, governments worldwide are investing in healthcare infrastructure and expanding healthcare coverage, driving demand for drug-eluting balloon catheters.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of drug-eluting balloon catheters. The growth and trends of drug-eluting balloon catheters industry provide a holistic approach to this study.
Market Segmentation
This section of the drug-eluting balloon catheters market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Drug
- Paclitaxel
- Sirolimus
- Others
By Indication
- Coronary Intervention
- Peripheral Intervention
By End-User
- Hospitals & ASCs
- Specialty Clinics And Catheterization Laboratories
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Drug-eluting Balloon Catheters market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Drug-eluting Balloon Catheters Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the drug-eluting balloon catheters market include Medtronic (Ireland), Koninklijke Philips N.V. (Netherlands), Boston Scientific Corporation (U.S.), BD (U.S.), B. Braun SE (Germany), Meril Life Sciences Pvt. Ltd. (India), BIOTRONIK (Germany), Cordis (U.S.), MicroPort Medical (Group) Co., Ltd. (China). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
